Global Childhood Hypertension Nearly Doubles in Two Decades

global-childhood-hypertension-nearly-doubles-in-two-decades
Representation image

A new meta-analysis published in The Lancet Child & Adolescent Health reveals that the rate of high blood pressure among children and adolescents worldwide nearly doubled between 2000 and 2020. In 2000, about 3.2% of children had hypertension. By 2020, this number rose to more than 6.2%, affecting an estimated 114 million young people under 19.

Obesity Emerges as a Major Driver

The study highlights obesity as a significant factor behind this surge. Nearly 19% of children and adolescents with obesity experience hypertension, compared to fewer than 3% of those with a healthy weight. “The nearly two-fold increase in childhood high blood pressure over 20 years should raise alarm bells for health care providers and caregivers,” said Prof. Igor Rudan, Director of the Center for Global Health Research at the University of Edinburgh. However, he emphasized that early screening and improved prevention strategies can help reduce future health risks.

How Measurement Methods Affect Estimates

As reported by medicalxpress, the researchers analyzed data from 96 large studies involving more than 443,000 children across 21 countries. They found that the method used to measure blood pressure significantly influences hypertension estimates.

Also Read |  Typhoid: An Ancient Disease Evolving Into a Modern Threat

When hypertension was confirmed over at least three clinical visits, prevalence reached 4.3%. However, when out-of-office assessments—such as ambulatory or home monitoring—were included, prevalence rose to 6.7%.

The study also revealed high rates of masked hypertension, affecting 9.2% of children. These cases go undetected during routine checkups, leading to missed diagnoses. In contrast, 5.2% of children exhibited white-coat hypertension, where blood pressure spikes only during clinic visits.

“Relying solely on in-office readings likely underestimates true prevalence or results in misdiagnosis,” said study author Dr. Peige Song of Zhejiang University School of Medicine. She called early detection and broader access to treatment essential to protect children as they age.

Obesity, Prehypertension and Rising Risks

The analysis further shows that children with obesity face nearly eight times the risk of developing hypertension. This elevated risk stems from obesity-related issues such as insulin resistance and blood vessel changes that make blood pressure harder to regulate.

Also Read |  OpenAI Launches ChatGPT Health for Personalized Health and Wellness Support

Additionally, around 8.2% of children and adolescents have prehypertension. Rates are especially high among teenagers, reaching 11.8%, compared to about 7% in younger children. Blood pressure also increases sharply around age 14, particularly among boys, underscoring the need for frequent screenings during early adolescence.

Study Limitations and Data Gaps

The authors note several limitations, including variations in measurement methods, study designs, and regional healthcare systems. Many included studies came from low- and middle-income countries, which may limit global comparisons. Moreover, some hypertension types and out-of-office monitoring data remain scarce.

Practical barriers—such as the limited availability of advanced blood pressure monitoring tools—also challenge widespread adoption of improved diagnostic approaches.

Urgent Call for Global Action

In a related commentary, Dr. Rahul Chanchlani of McMaster University stressed the need for standardized diagnostic criteria, expanded monitoring beyond clinics, and improved surveillance systems. He also called for better education of healthcare providers, families, and policymakers.

He emphasized that childhood hypertension must be integrated into broader non-communicable disease prevention strategies.
“Cardiovascular risk begins not in middle age, but in childhood,” he wrote. “The task ahead is straightforward: ensure that no child’s elevated blood pressure goes undetected, unrecognized, or untreated.”

Also Read |  Study Reveals How Lecanemab Works to Clear Amyloid Plaques in Alzheimer’s Disease